Triple

T15983055
Position Surface form Disambiguated ID Type / Status
Subject Juno Therapeutics E387620 entity
Predicate productCandidate P64697 FINISHED
Object JCAR017
JCAR017 is an investigational CAR T-cell therapy developed by Juno Therapeutics for the treatment of certain blood cancers.
E1188118 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: JCAR017 | Statement: [Juno Therapeutics, productCandidate, JCAR017]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: JCAR017
Context triple: [Juno Therapeutics, productCandidate, JCAR017]
  • A. J1
    J1 is the top professional football (soccer) division in Japan, featuring the country’s highest-level clubs.
  • B. Coutras
    Coutras is a commune in southwestern France known historically as the site of a major battle during the French Wars of Religion.
  • C. Karsen
    Karsen is a given name that can be used for people of any gender.
  • D. CJC
    CJC is the IATA airport code for El Loa Airport serving the city of Calama in northern Chile.
  • E. CJC
    CJC is the commonly used abbreviation for the College of Journalism and Communications, an academic institution focused on media, journalism, and communication studies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: JCAR017
Triple: [Juno Therapeutics, productCandidate, JCAR017]
Generated description
JCAR017 is an investigational CAR T-cell therapy developed by Juno Therapeutics for the treatment of certain blood cancers.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: JCAR017
Target entity description: JCAR017 is an investigational CAR T-cell therapy developed by Juno Therapeutics for the treatment of certain blood cancers.
  • A. J1
    J1 is the top professional football (soccer) division in Japan, featuring the country’s highest-level clubs.
  • B. Coutras
    Coutras is a commune in southwestern France known historically as the site of a major battle during the French Wars of Religion.
  • C. Karsen
    Karsen is a given name that can be used for people of any gender.
  • D. CJC
    CJC is the IATA airport code for El Loa Airport serving the city of Calama in northern Chile.
  • E. CJC
    CJC is the commonly used abbreviation for the College of Journalism and Communications, an academic institution focused on media, journalism, and communication studies.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: productCandidate
Context triple: [Juno Therapeutics, productCandidate, JCAR017]
  • A. productFor
    Indicates that one entity is intended to be used by, with, or in relation to another entity as its product or offering.
  • B. productVariant chosen
    Indicates that one entity is a specific variant or version of a more general product entity.
  • C. productForm
    Indicates the specific physical or presentation format in which a product is offered or delivered (e.g., tablet, liquid, package type).
  • D. productStandard
    Indicates that an entity complies with, is governed by, or is defined according to a particular product-related standard or specification.
  • E. productDomain
    Indicates the domain, field, or area of application to which a given product belongs or is relevant.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e17d4d08f481909f38b75e3f42d9ab completed April 17, 2026, 12:22 a.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3cdf7848190848e9081027dc027 completed May 9, 2026, 11:31 p.m.
NEDg Description generation batch_69ffc5669c1c81909bacf61c96cb7816 completed May 9, 2026, 11:38 p.m.
NED2 Entity disambiguation (via description) batch_69ffc5c7db1c8190b4e1de6f6e3ce8a0 completed May 9, 2026, 11:39 p.m.
PD Predicate disambiguation batch_69e142d9d8e881909b559a3e3ca21d24 completed April 16, 2026, 8:13 p.m.
Created at: April 10, 2026, 4:54 a.m.